Search

everythinglearnresearchcommunity

for

Search:↓

All five hair fiber products improved appearance but didn't stick to completely bald areas.

A 4-year-old girl with hair loss was diagnosed with early-onset trichotillomania and improved with behavioral interventions.

Hair loss in women can be treated with hormone therapy.

Macrophage iron release is crucial for hair growth and wound healing.

Eating too much selenium can cause bad breath, hair loss, and nail changes, with harmful effects starting at low daily doses.

Exosome therapy shows promise for treating skin conditions and improving wound healing.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Topical drugs can target hair follicles to treat skin conditions more effectively.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Substances from dental stem cells might help treat hair loss.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Dermatologists need better training on Black hair to improve care and outcomes.

Hair analysis can help identify specific minerals and amino acids linked to various diseases.

Thicker hair grows faster; hair loss patients have slower growth.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Honey has many health benefits and is good for you.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Finasteride effectively treats baldness but may cause sexual side effects.

Better hair loss models needed for research.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.